Average Co-Inventor Count = 9.40
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nimbus Saturn, Inc. (10 from 10 patents)
2. Pfizer Corporation (9 from 4,455 patents)
3. Wyeth (4 from 1,309 patents)
4. Nimbus Clotho, Inc. (1 from 1 patent)
24 patents:
1. 12466841 - Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists
2. 12331046 - CTPS1 inhibitors and uses thereof
3. 12252488 - HPK1 antagonists and uses thereof
4. 12215105 - HPK1 antagonists and uses thereof
5. 12071442 - Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists
6. 11926625 - HPK1 antagonists and uses thereof
7. 11548890 - HPK1 antagonists and uses thereof
8. 11078201 - Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrol[3,4-c]pyridin-1-ones as HPK1 antagonists
9. 11034694 - Substituted isoindolin-1-ones and 2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists
10. 11028085 - Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as hpk1 antagonists
11. 11021481 - Substituted isoindolin-1-ones and 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-ones as HPK1 antagonists
12. 10966980 - Pyrrolo[2,3-d]pyrimidine derivatives
13. 10426135 - Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof
14. 10385036 - Sulfonamide-substituted indole modulators of RORC2 and methods of use thereof
15. 10336748 - Methyoxy-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof